Home / Resources / Nordic Life Science Days – Hunt for the Next Big Thing Within Big Pharma

Nordic Life Science Days – Hunt for the Next Big Thing Within Big Pharma

Video
Commercial
Event banner for the NLSDays 2024

Speakers from five of the biggest global pharmaceutical companies, all involved in innovation and partnering, share their insights in this informative panel discussion.

There are many ways to find the next big thing, and sometimes it drops into your lap.
Eleanor Malone, Editor-in-Chief, Commercial Insights, Citeline
Related products
Expert interview with a biopharma leader for insights and strategy.
In Vivo
Interviews, analysis and critical insights for life science decision-makers
Professionals accessing Scrip for the latest industry news and developments to gain advantage on competition.
Scrip
Global pharmaceutical industry news that goes beyond the headlines
New medicine product news and analysis are included in Citeline's Generics Bulletin offerings.
Generics Bulletin
Unrivaled news and analysis of the global generics, biosimilars and value-added medicines industries

Related resources

A variety of pills and tablets arranged neatly on a wooden table surface
OCT 09, 2024
Report
Commercial

Key Potential Drug Launches in 2025

Biomedtracker’s Key Potential Drug Launches in 2025 report provides a longer-term look at some key late-stage drugs projected to hit the market in 2025.

Stacks of coins arranged in ascending order with a white arrow and line graph overlay indicating growth
JUN 11, 2024
eBook
Commercial

Billion Dollar Blueprint: The Journey to Blockbuster Status

A deep dive into the dynamics of blockbuster drugs. Using data from Evaluate Pharma, Scrip surveys the existing field of these top-tier products, examines the role that multiple indications play and the time it takes to reach blockbuster status, and considers whether there is an advantage for in-house or external assets.

Citeline professional presenting the Q4 2024 Outlook Report provided by Biomedtracker.
SEP 30, 2024
Report
Commercial

Q4 Outlook Report: Key Industry Drugs, Devices & Deals

In this report, we cover catalysts from 24 drugs, devices, diagnostics, and deals expected to occur in Q4 2024.

View all